Lonza Group AG, headquartered in Basel, Switzerland, is a global leader in pharmaceutical, biotechnology, and nutrition manufacturing. Founded in 1897, Lonza specializes in product development and custom biopharmaceutical manufacturing. With operations in 35 countries and over 17,500 employees, Lonza is a key player in healthcare, partnering with top pharmaceutical companies and contributing to the production of essential therapies. The company excels in biologics, cell and gene technologies, and active pharmaceutical ingredients.